Press

Society for Neuro-Oncology 29th Annual Meeting & Education Day
The Hallmarks of Brain Cancer
November 21-24, 2024
George R. Brown Convention Center
Houston, Texas

CALL FOR ABSTRACTS

Share your research with your colleagues at the world’s largest neuro-oncology conference!
Abstract Submission
Deadline: May 29, 2024 at 11:59 PM ET

The 29th Annual Meeting and Education Day of the Society for Neuro-Oncology will take place on November 21–24, 2024, at the George R. Brown Convention Center in Houston, Texas! The theme of this year’s meeting is The Hallmarks of Brain Cancer. 

The SNO Annual Meeting is the world’s largest neuro-oncology conference, regularly attracting over 2600 researchers and clinician-scientists from over 40 countries. Spanning all neuro-oncology disciplines, professions, and sectors, the SNO2024 will be the premier forum at which to share knowledge and gain insights on the future of neuro-oncology research and treatment.    

ABSTRACT SUBMISSION
The Call for Abstracts for the 2024 SNO Annual Meeting is now open! The abstract deadline is Wednesday, May 29, 2024, at 11:59 pm ET. This deadline will not be extended. Be a part of the largest neuro-oncology conference in the world by submitting your scientific research today!

DEADLINES

• The regular abstract submission deadline is Wednesday, May 29, 2024, at 11:59 PM ET. This deadline will not be extended. NOTE: Abstracts including titles, content, and authors, cannot be edited after the May 29 deadline. Acceptance notifications will be sent in late July or early August.
• The late breaking abstract deadline is Tuesday, September 3, 2024, at 5:00 PM ET. Only abstracts related to late phase clinical trials will be accepted for late breaking consideration. A placeholder abstract must be submitted by the initial May 29 deadline. Submitters who do not submit a placeholder abstract by the May 29 deadline will not be allowed to submit a late breaking abstract at a later date. Please carefully review the late breaking guidelines prior to submitting a late breaking abstract. Acceptance notifications will be sent after the final September 3 deadline.
• All accepted abstracts will be published as submitted in the journal Neuro-Oncology. Once the abstracts are submitted to the journal for publication, requests for withdrawals cannot be processed. All requests to withdraw must be submitted by Monday, August 5, 2024, at 5:00 PM ET.
• The presenter registration deadline is Tuesday, October 15. All abstract presenters (oral and poster) must present in person at the meeting in Houston and must register for the meeting by the deadline.

PERMISSIONS

• All accepted abstracts will be published as submitted in the journal Neuro-Oncology. Submitters will be required to provide permission to publish. There are no exceptions.
• All presentations will be recorded and will be made available on SNO’s website for approximately one year following the meeting. Submitters will be required to provide permission to record. There are no exceptions.
• The abstract submitter must confirm that all authors have approved the abstract submission.
• The abstract submitter must confirm that the presenter or another author will register for and present the accepted abstract at the meeting.
• Presenters will be given full credit for their presentations. For the purpose of Neuro-Oncology, Neuro-Oncology Practice and other scholarly journals, presentation in either of these forums is not considered “prior publication”.

REGISTRATION REQUIREMENTS

• All listed abstract presenters (oral and poster) MUST register for the meeting by Tuesday, October 15. Presenters must present their abstract in person at the meeting in Houston, Texas. Virtual or pre-recorded presentations will not be possible. If you have a presenter change, you must notify Tara Mammoser at [email protected] via email. If the listed presenter is not registered by the registration deadline, the abstract will be withdrawn from the meeting.

EMBARGO DETAILS

• The embargo will be lifted for regular abstracts on November 11, 2024, at 7:00 AM ET. Late breaking abstracts will be released the day of presentation.
• Press releases may be issued after the embargo is lifted. However, we ask that you do not release the presentation slides or poster until after the presentation at the meeting.

SUBMITTER/PRESENTER RESPONSIBILITES

• Presenters using a third party to create slides and/or posters are responsible to communicate presentation details and specifications with the third party.
• Poster presenters will be required to submit an electronic version of their traditional poster they will hang and display at the meeting. The electronic version will be available for attendees to view on the SNO website and mobile app for approximately one year following the meeting.
• Initial communication will be sent to the abstract submitter and later to the presenter (if different than the submitter).
• Communication regarding your presentation and other details will be sent to the email address provided by the submitter. Please be sure to verify the submitter's and presenter’s email addresses. SNO is not responsible for verifying email addresses.

ABSTRACT AWARDS

• All submitted abstracts (except for Late Breaking Abstracts) are automatically considered for subject matter awards. In addition, abstract submitters may also indicate their willingness to be considered for the Women in Neuro-Oncology (WiN) Awards, Young Investigator Award and the EANO Travel Scholarships. Please note, the presenting authors will receive all awards.
  • The WiN Abstract Awards recognize two outstanding abstracts, with a designation of an oral presentation during a session of the SNO Annual Meeting and presentation of an award certificate. One is given for Basic/Translational Science Research and the other for Clinical Research.
  • Young Investigator Awards recognize outstanding abstracts with the designation of an oral presentation during a session of the SNO Annual Meeting, an award certificate, and a monetary award. To be considered a Young Investigator, applicants must be within the first five years of a faculty appointment (tenure or non-tenure track) within their institution. Postdoctoral fellows, research associates below faculty level are not eligible.
  • EANO Travel Scholarships: SNO and EANO are awarding reciprocal travel scholarships to their respective meetings (EANO in Glasgow, Scotland, United Kingdom on October 17-20, 2024, and SNO in Houston, Texas on November 21-24, 2024). A joint committee of the scientific leadership of both organizations will review top-scoring abstracts to select the winners who will present oral abstracts. Airfare, hotel stipend and registrations fees for travel to Glasgow, Scotland will be provided for the SNO scholarship recipients. Please note that applying for this award does not preclude you from presenting your work in Houston.

CONTENT OF ABSTRACTS

• Please review the track and submission category details prior to submitting an abstract.
• Abstract submitters should carefully review their abstract for content errors (spelling, names, etc.) before submitting. SNO neither proofreads for nor corrects spelling, typographical, grammatical, or scientific errors. Accepted abstracts will be published as submitted in the journal Neuro-Oncology. Abstract edits cannot be made after the May 29 deadline.
• Abstract Title
• Should be sentence case (i.e., only the first letter of the sentence should be capitalized).
• Should be plain text (no html).
• Word Limit: 75 words.
• Abstract Body
• Figures and tables are not allowed.
• If sub-headers are used (i.e., Background, Methods, Results, Conclusions), they should be included in the paragraph and not bolded.
• Abstracts should be data-driven and must include this information in the body of the abstract.
• Word Limit: 300 words.
• Authors
• There can only be one presenting author per abstract submission. If the listed presenting author is unable to present, a co-author will be allowed to present in their place. All presenter changes must be sent via email to Tara Mammoser at [email protected] .
• Enter the names of authors in the order in which you wish them to appear on the meeting website and in the journal.
• Communication will be sent to the email addresses provided by the submitter. The submitter should verify the entered email addresses. SNO is not responsible for verifying email addresses.
• Submitters should verify spelling and institutional affiliations of authors. SNO neither proofreads for nor corrects spelling or institutional affiliation errors.
• Author Limit: 50 authors with a maximum of 2 affiliations per author.
• Authors cannot be edited or added after the May 29 deadline. 

TRACK & SUBMISSION CATEGORY DETAILS

• The submitter must select a special interest track and category that is most related to your abstract. NOTE: Upon review, the SNO Annual Meeting Planning Committee reserves the right to change the special interest track and category originally selected by the abstract submitter.
• For Late Breaking Abstract information and guidelines please click here .

PLANNING COMMITTEE LEADERSHIP

Annual Meeting Co-Chairs:
Michelle Monje, Stanford University
Humsa Venkatesh, Brigham and Women's Hospital and Harvard Medical School
Howard Colman, University of Utah
Erik Sulman, New York University Grossman School of Medicine

Education Day Co-Chairs:
Applied Science Path:
Stephen J. Bagley, University of Pennsylvania
Lindsay B. Kilburn, Children’s National Hospital